{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:03:42Z","timestamp":1792641822906,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2170,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/labinvest.2016.142","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T08:42:16Z","timestamp":1483951336000},"page":"146-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"title":["The NF1 gene in tumor syndromes and melanoma"],"prefix":"10.1016","volume":"97","author":[{"given":"Maija","family":"Kiuru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus J","family":"Busam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2016.142_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Cell"},{"key":"10.1038\/labinvest.2016.142_bib2","unstructured":"von Recklinghausen F . Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Berlin: Hirschwald, 1882."},{"key":"10.1038\/labinvest.2016.142_bib3","unstructured":"Crowe FW SW, Neel JV . A Clinical, Pathological and Genetic Study of Multiple Neurofibromatosis. Springfield, IL: CC Thomas, 1956."},{"key":"10.1038\/labinvest.2016.142_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1038\/labinvest.2016.142_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1038\/labinvest.2016.142_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/labinvest.2016.142_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"J Med Genet"},{"key":"10.1038\/labinvest.2016.142_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/gcc.2870010107","article-title":"Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17","volume":"1","author":"Skuse","year":"1989","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/labinvest.2016.142_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/labinvest.2016.142_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1523-1747.ep12676518","article-title":"Ultrastructure of giant pigment granules (macromelanosomes) in the cutaneous pigmented macules of neurofibromatosis","volume":"61","author":"Jimbow","year":"1973","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2016.142_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199105023241807","article-title":"Lisch nodules in neurofibromatosis type 1","volume":"324","author":"Lubs","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2016.142_bib12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","article-title":"Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases","volume":"137","author":"Wolkenstein","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/labinvest.2016.142_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","article-title":"Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas","volume":"4","author":"Le","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1038\/labinvest.2016.142_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","article-title":"Association between benign and malignant peripheral nerve sheath tumors in NF1","volume":"65","author":"Tucker","year":"2005","journal-title":"Neurology"},{"key":"10.1038\/labinvest.2016.142_bib15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population","volume":"79","author":"Zoller","year":"1997","journal-title":"Cancer"},{"key":"10.1038\/labinvest.2016.142_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1038\/labinvest.2016.142_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00008390-200404000-00014","article-title":"Cutaneous malignant melanoma and neurofibromatosis type 1","volume":"14","author":"Guillot","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1038\/labinvest.2016.142_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.survophthal.2014.08.001","article-title":"Desmoplastic melanoma of the eyelid and conjunctival melanoma in neurofibromatosis type 1: a clinical pathological correlation","volume":"60","author":"Rubinstein","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"10.1038\/labinvest.2016.142_bib19","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.3107130","article-title":"Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17","volume":"236","author":"Barker","year":"1987","journal-title":"Science"},{"key":"10.1038\/labinvest.2016.142_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/jmg.24.9.536","article-title":"A genomic search for linkage of neurofibromatosis to RFLPs","volume":"24","author":"Barker","year":"1987","journal-title":"J Med Genet"},{"key":"10.1038\/labinvest.2016.142_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0888-7543(87)90034-6","article-title":"Genetic analysis of NF1: identification of close flanking markers on chromosome 17","volume":"1","author":"Fain","year":"1987","journal-title":"Genomics"},{"key":"10.1038\/labinvest.2016.142_bib22","first-page":"6","article-title":"Multipoint linkage analysis in neurofibromatosis type I: an international collaboration","volume":"44","author":"Goldgar","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib23","first-page":"721","article-title":"Refined physical and genetic mapping of the NF1 region on chromosome 17","volume":"45","author":"Fain","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib24","first-page":"68","article-title":"The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints","volume":"44","author":"Fain","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(91)90017-9","article-title":"cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product","volume":"11","author":"Marchuk","year":"1991","journal-title":"Genomics"},{"key":"10.1038\/labinvest.2016.142_bib26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1346-8138.1992.tb03799.x","article-title":"The neurofibromatosis type 1 (NF1) gene: identification and partial characterization of a putative tumor suppressor gene","volume":"19","author":"O'Connell","year":"1992","journal-title":"J Dermatol"},{"key":"10.1038\/labinvest.2016.142_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.pediatrneurol.2013.02.004","article-title":"Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1","volume":"48","author":"Ko","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1038\/labinvest.2016.142_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/gtmb.2014.0109","article-title":"The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study","volume":"18","author":"Maruoka","year":"2014","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1038\/labinvest.2016.142_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12031-014-0286-7","article-title":"Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene","volume":"53","author":"Balla","year":"2014","journal-title":"J Mol Neurosci"},{"key":"10.1038\/labinvest.2016.142_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1038\/labinvest.2016.142_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/gcc.2870030111","article-title":"Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis","volume":"3","author":"Glover","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/labinvest.2016.142_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/gcc.2870040411","article-title":"Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis","volume":"4","author":"Xu","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/labinvest.2016.142_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ng0293-122","article-title":"Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis","volume":"3","author":"Legius","year":"1993","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199403033300903","article-title":"Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders","volume":"330","author":"Shannon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2016.142_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng0995-90","article-title":"Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene","volume":"11","author":"Colman","year":"1995","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0996-110","article-title":"Identification of NF1 mutations in both alleles of a dermal neurofibroma","volume":"14","author":"Sawada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib37","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1038\/labinvest.2016.142_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/374821","article-title":"Elevated risk for MPNST in NF1 microdeletion patients","volume":"72","author":"De Raedt","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-7364-6-12","article-title":"Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?","volume":"6","author":"Alkindy","year":"2012","journal-title":"Hum Genomics"},{"key":"10.1038\/labinvest.2016.142_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant","year":"2012","journal-title":"J Med Genet"},{"key":"10.1038\/labinvest.2016.142_bib42","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/jnci\/djr416","article-title":"Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1","volume":"103","author":"Pasmant","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/labinvest.2016.142_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-14-1891","article-title":"The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients","volume":"75","author":"Warrington","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pcmr.12488","article-title":"Multiple roles of NF1 in the melanocyte lineage","volume":"29","author":"Larribere","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/labinvest.2016.142_bib45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1038\/labinvest.2016.142_bib46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/hmg\/7.8.1261","article-title":"Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1","volume":"7","author":"Klose","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1038\/labinvest.2016.142_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CCO.0000000000000271","article-title":"The role of mitogen-activated protein targeting in melanoma beyond BRAFV600","volume":"28","author":"Sullivan","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/labinvest.2016.142_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.36793","article-title":"Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues","volume":"167A","author":"Rauen","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1038\/labinvest.2016.142_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","article-title":"Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes","volume":"157C","author":"Kratz","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1038\/labinvest.2016.142_bib51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2009-04-218503","article-title":"SPRED1 disorder and predisposition to leukemia in children","volume":"114","author":"Pasmant","year":"2009","journal-title":"Blood"},{"key":"10.1038\/labinvest.2016.142_bib52","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib53","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"JAMA"},{"key":"10.1038\/labinvest.2016.142_bib54","doi-asserted-by":"crossref","first-page":"E1985","DOI":"10.1002\/humu.21404","article-title":"Legius syndrome in fourteen families","volume":"32","author":"Denayer","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1038\/labinvest.2016.142_bib55","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399409001227","article-title":"Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways","volume":"11","author":"Katz","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"10.1038\/labinvest.2016.142_bib56","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/labinvest.2016.142_bib57","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib58","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/0008-5472.CAN-11-4092","article-title":"PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors","volume":"72","author":"Keng","year":"2012","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.stem.2007.07.008","article-title":"Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms","volume":"1","author":"Hegedus","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1038\/labinvest.2016.142_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1038\/labinvest.2016.142_bib61","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2014.07.054","article-title":"Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1","volume":"8","author":"Wolman","year":"2014","journal-title":"Cell Rep"},{"key":"10.1038\/labinvest.2016.142_bib62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/aja.1001950307","article-title":"Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development","volume":"195","author":"Daston","year":"1992","journal-title":"Dev Dyn"},{"key":"10.1038\/labinvest.2016.142_bib63","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jnr.490360212","article-title":"Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation","volume":"36","author":"Gutmann","year":"1993","journal-title":"J Neurosci Res"},{"key":"10.1038\/labinvest.2016.142_bib64","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1101\/gad.490608","article-title":"NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F","volume":"22","author":"Parrinello","year":"2008","journal-title":"Genes Dev"},{"key":"10.1038\/labinvest.2016.142_bib65","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.jid.5701095","article-title":"Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes","volume":"128","author":"De Schepper","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2016.142_bib66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1242\/jcs.013912","article-title":"Neurofibromin as a regulator of melanocyte development and differentiation","volume":"121","author":"Diwakar","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1038\/labinvest.2016.142_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/jid.2012.240","article-title":"Differential effects of neurofibromin gene dosage on melanocyte development","volume":"133","author":"Deo","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2016.142_bib68","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1073\/pnas.1019070108","article-title":"Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis","volume":"108","author":"Nissan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/labinvest.2016.142_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pcmr.12369","article-title":"NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model","volume":"28","author":"Larribere","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/labinvest.2016.142_bib70","doi-asserted-by":"crossref","first-page":"9034","DOI":"10.1073\/pnas.1501032112","article-title":"In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells","volume":"112","author":"Allouche","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/labinvest.2016.142_bib71","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib72","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomicsdata","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1038\/labinvest.2016.142_bib73","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib74","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib75","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1038\/labinvest.2016.142_bib76","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib77","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Cancer Genome Atlas Research Network","year":"2012","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib79","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1038\/labinvest.2016.142_bib80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eururo.2014.06.050","article-title":"Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder","volume":"67","author":"Kim","year":"2015","journal-title":"Eur Urol"},{"key":"10.1038\/labinvest.2016.142_bib81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib82","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/ncomms6006","article-title":"Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes","volume":"5","author":"Jones","year":"2014","journal-title":"Nat Commun"},{"key":"10.1038\/labinvest.2016.142_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib84","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib85","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1038\/labinvest.2016.142_bib86","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib87","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib88","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib89","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s004390000374","article-title":"Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma","volume":"107","author":"Gutzmer","year":"2000","journal-title":"Hum Genet"},{"key":"10.1038\/labinvest.2016.142_bib90","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.3361","article-title":"Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas","volume":"47","author":"Krauthammer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib91","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1038\/labinvest.2016.142_bib93","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"10.1038\/labinvest.2016.142_bib94","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1158\/1078-0432.CCR-13-0398","article-title":"BRAF\/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage","volume":"19","author":"Mar","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib95","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-13-2625","article-title":"Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence","volume":"74","author":"Nissan","year":"2014","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib96","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0000000000000451","article-title":"NF1 Mutations Are Common in Desmoplastic Melanoma","volume":"39","author":"Wiesner","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/labinvest.2016.142_bib97","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/labinvest.2016.142_bib98","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/PAS.0000000000000201","article-title":"Desmoplastic melanoma with sarcomatoid dedifferentiation","volume":"38","author":"Kiuru","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/labinvest.2016.142_bib99","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.20601","article-title":"Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)","volume":"29","author":"Upadhyaya","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1038\/labinvest.2016.142_bib100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/path.2494","article-title":"Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours","volume":"217","author":"Bottillo","year":"2009","journal-title":"J Pathol"},{"key":"10.1038\/labinvest.2016.142_bib101","series-title":"Histological Diagnosis of Nevi and Melanoma","first-page":"437","article-title":"Desmoplastic Melanoma","author":"Massi","year":"2014"},{"key":"10.1038\/labinvest.2016.142_bib102","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jid.2016.05.095","article-title":"RASopathy Gene Mutations in Melanoma","volume":"136","author":"Halaban","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2016.142_bib103","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11864-015-0328-6","article-title":"Current treatment options for malignant peripheral nerve sheath tumors","volume":"16","author":"Bradford","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"10.1038\/labinvest.2016.142_bib104","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/pbc.25546","article-title":"Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1","volume":"62","author":"Jousma","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1038\/labinvest.2016.142_bib105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOP.0000000000000169","article-title":"Neurofibromatosis-related tumors: emerging biology and therapies","volume":"27","author":"Karajannis","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"10.1038\/labinvest.2016.142_bib106","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","article-title":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas","volume":"16","author":"Karajannis","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1038\/labinvest.2016.142_bib107","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1200\/JCO.2007.14.4956","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1\/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers","volume":"26","author":"Adjei","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/labinvest.2016.142_bib108","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1038\/labinvest.2016.142_bib109","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1078-0432.CCR-09-2483","article-title":"The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1\/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer","volume":"16","author":"Banerji","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib110","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2014.6096","article-title":"Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial","volume":"311","author":"Carvajal","year":"2014","journal-title":"JAMA"},{"key":"10.1038\/labinvest.2016.142_bib111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10637-014-0191-5","article-title":"Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors","volume":"33","author":"Dickson","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1038\/labinvest.2016.142_bib112","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1158\/0008-5472.CAN-13-1825","article-title":"Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma","volume":"73","author":"Nakamura","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2016.142_bib113","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1476-4598-13-194","article-title":"Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma","volume":"13","author":"Wong","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1038\/labinvest.2016.142_bib114","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/pcmr.12303","article-title":"Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS-mutant melanoma","volume":"27","author":"Rebecca","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/labinvest.2016.142_bib115","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/2159-8290.CD-12-0470","article-title":"A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition","volume":"3","author":"Whittaker","year":"2013","journal-title":"Cancer Discov"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722022723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722022723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:47:18Z","timestamp":1758397638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722022723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0023683722022723"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2016.142","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NF1 gene in tumor syndromes and melanoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2016.142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}